AVNP AVNP
Home
* SEEDA
* * * *
* * * *
* > Home *
* * * *
* * * *
* * * *
* > AVNP Partners *
* * * *
* * * *
* * * *
* > Programme *
* * * *
* * * *
* * * *
* > Contact *
* * * *
* * * *
* * * *
* > Enquiry Form *
* * * *
* * * *
* * * *
* > Antiviral nanoparticles programme to address epidemics *
* * * *
* * * *

AVNP

Team AVNP, a closely linked and complementary team of University and Industrial Partners, proposes to accelerate rapidly the development and commercialisation of an innovative new health product - an anti-viral nanomaterial targeted initially at pandemic viruses such as H5N1 Bird Flu, but with potential to be a broad spectrum antiviral material.

*

This project is funded by the South East England Development Agency.

To read the Press Release click here
* > AVNP Partners
Partners in the Programme
* * *
* > Programme
This project is based on results obtained over the last three years on nanomaterials that demonstrate an antiviral effect.
* * *
*
Email us * Email us * Telephone number * 44 (0)1252 393000 * Postal address * Postal address
Privacy statement | Cookie Policy | Conditions of use | Copyright information | Legal information © QinetiQ Ltd 2007
QinetiQ Group plc,  Company Registration No 4586941,  Registered office 85 Buckingham Gate, London SW1E 6PD